AlphaYou
Overview
Smart money at a glance
Filings to Oct 11, 2026Net selling: insiders sold $432K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$432K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 0 added, 1 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 10- Open
- $2.59
- 52-wk high
- $5.45
- High
- $2.69
- 52-wk low
- $2.42
- Low
- $2.54
- Prev close
- $2.63
- Mkt cap
- $281.0M
- Volume
- 3.37M
- Beta
- 0.50
- P/B
- 0.9x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -4.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about RCKT filings
Are insiders buying or selling Rocket Pharmaceuticals Inc (RCKT) stock?
Net selling: insiders sold $432K and bought $0 of RCKT stock on the open market in the 90 days to Oct 11, 2026, according to SEC Form 4 filings. The largest was Wilson, Martin (General Counsel), who sold $270K. The latest filing was on Sep 16, 2026.
Which members of Congress have traded RCKT recently?
None. No member of Congress disclosed a RCKT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this RCKT smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- AQ
AQR
$8.5M
added
- SS
State Street
$10.1M
added
Sells/Trims (1)
- SS
State Street
$9.8M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in RCKT right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $0.43 a share below what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.28 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.15 / $0.28Alpha Vantage | -$0.43 miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.42 / -$0.45Alpha Vantage | +6.67% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | -$0.38 / -$0.42Alpha Vantage | +9.52% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$0.45 / -$0.52Alpha Vantage | +13.46% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$0.59 / -$0.57Alpha Vantage | -3.51% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$0.56 / -$0.58Alpha Vantage | +3.45% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | -$0.62 / -$0.72Alpha Vantage | +13.64% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | -$0.71 / -$0.75Alpha Vantage | +5.33% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 25 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | — | — | $2.1M | — |
| Gross profit | — | — | -$2.1M | — |
| What it spent | ||||
| Research and development | $34.1M | $29.3M | $31.5M | $29.5M |
| Sales and admin | $18.4M | $14.7M | $17.1M | $17.4M |
| Other operating costs | — | — | -$2.1M | — |
| Total operating expenses | $52.2M | $44.0M | $46.4M | $46.9M |
| What was left | ||||
| Operating profit | -$52.2M | -$44.0M | -$48.5M | -$46.9M |
| Interest on debt | $473.0K | $3.3M | $473.0K | $473.0K |
| Profit before tax | -$50.3M | -$42.5M | -$47.6M | $131.8M |
| Tax | — | — | — | $8.6M |
| Net profit | -$50.3M | -$42.5M | -$47.6M | $123.2M |
| EBITDA | -$46.6M | -$37.0M | -$45.0M | $134.4M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace